[ad_1] The FDA has granted lorlatinib (Lorbrena) an accelerated approval for the treatment of patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on 1 or more ALK tyrosine …
Read More »
[ad_1] BAccording to a new study, anti-stress pills taken by millions of patients could increase the risk of lung cancer by almost a third. A study of nearly one million Britons showed …
Read More »
[ad_1] The Guardant360 test detects DNA segments in the patient's blood from the cancerous tumor or its metastasis Image of representation Israeli researchers have discovered a method to tailor specific treatment to …
Read More »